Abstract

The current COVID-19 pandemic has triggered innovations in therapeutic strategies that are thought to provide viable and faster pathways to cure infected people by the deadly virus, SARSCoV-2. In this review, we have described the known epidemiology along with the discovered genome structure and viral factors of SARS-CoV-2. Further, the latest innovations in therapeutics including significant breakthroughs in clinical trials on antiviral drugs, rendesivir and chloroquine including the combination drugs have been highlighted. This brief overview on therapeutic strategies should serve a medium to researchers for further innovations in drug discovery and repurposing of anti-viral drugs for SARS-CoV-2.